Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway

« Previous Next »The American Journal of Surgery
Volume 197, Issue 3 , Pages 313-319, March 2009

Scott N. Pinchot, M.D.
- Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, Madison, WI, USA
Joel T. Adler, B.A.
- Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, Madison, WI, USA
Yinggang Luo, Ph.D.
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, USA
Jianhua Ju, Ph.D.
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, USA
Wenli Li, Ph.D.
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, USA
Ben Shen, Ph.D.
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, USA
- University of Wisconsin National Cooperative, Drug Discovery Group, Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA
Muthusamy Kunnimalaiyaan, Ph.D.
- Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, Madison, WI, USA
Herbert Chen, M.D., F.A.C.S
- Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin, Madison, WI, USA
- Corresponding author. Tel.: +01-608-263-1387; fax: +01-608-263-7652